70 related articles for article (PubMed ID: 21361082)
21. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
22. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
[TBL] [Abstract][Full Text] [Related]
23. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas.
Fillies T; Woltering M; Brandt B; Van Diest JP; Werkmeister R; Joos U; Buerger H
Oncol Rep; 2007 Feb; 17(2):355-9. PubMed ID: 17203174
[TBL] [Abstract][Full Text] [Related]
25. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma.
Hidaka T; Hama S; Shrestha P; Saito T; Kajiwara Y; Yamasaki F; Sugiyama K; Kurisu K
Anticancer Res; 2009 Feb; 29(2):597-603. PubMed ID: 19331209
[TBL] [Abstract][Full Text] [Related]
26. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
27. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up.
Mansour OA; Zekri AR; Harvey J; Teramoto Y; el-Ahmady O
Anticancer Res; 1997; 17(4B):3101-6. PubMed ID: 9329611
[TBL] [Abstract][Full Text] [Related]
28. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
[TBL] [Abstract][Full Text] [Related]
29. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
30. Combined overexpression of c-erbB-2 protein and epidermal growth factor receptor (EGF-R) could be predictive of early and long-term outcome in human breast cancer: a pilot study.
Delarue JC; Terrier P; Terrier-Lacombe MJ; Mouriesse H; Gotteland M; May-Levin F
Bull Cancer; 1994 Dec; 81(12):1067-77. PubMed ID: 7742595
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.
Bodey B; Kaiser HE; Siegel SE
In Vivo; 2005; 19(5):931-41. PubMed ID: 16097449
[TBL] [Abstract][Full Text] [Related]
32. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
33. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
34. Negative prognostic impact of the coexpression of epidermal growth factor receptor and c-erbB-2 in locally advanced cervical cancer.
Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Mendiola C; Alonso L; Alba E; Lanzós E
Oncology; 2009; 76(2):133-41. PubMed ID: 19174612
[TBL] [Abstract][Full Text] [Related]
35. Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.
Robertson KW; Reeves JR; Smith G; Keith WN; Ozanne BW; Cooke TG; Stanton PD
Cancer Res; 1996 Aug; 56(16):3823-30. PubMed ID: 8706030
[TBL] [Abstract][Full Text] [Related]
36. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
[TBL] [Abstract][Full Text] [Related]
37. RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
Zlobec I; Baker K; Terracciano LM; Lugli A
Clin Cancer Res; 2008 Jun; 14(12):3798-806. PubMed ID: 18559599
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients.
Xia W; Chen JS; Zhou X; Sun PR; Lee DF; Liao Y; Zhou BP; Hung MC
Clin Cancer Res; 2004 Jun; 10(11):3815-24. PubMed ID: 15173090
[TBL] [Abstract][Full Text] [Related]
39. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
DiGiovanna MP; Stern DF; Edgerton SM; Whalen SG; Moore D; Thor AD
J Clin Oncol; 2005 Feb; 23(6):1152-60. PubMed ID: 15718311
[TBL] [Abstract][Full Text] [Related]
40. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study.
Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
Clin Cancer Res; 1999 Oct; 5(10):2848-53. PubMed ID: 10537352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]